Price Alert

Kyverna Therapeutics Inc. (KYTX)

NASDAQ: KYTX · Real-Time Price · USD

3.94

0.31 (8.54%)

At close: Sep 05, 2025, 3:59 PM

3.92

-0.53%

After-hours: Sep 05, 2025, 05:37 PM EDT

8.54% (1D)

Bid	3.56
Market Cap	170.39M
Revenue (ttm)	2.02M
Net Income (ttm)	-158.7M
EPS (ttm)	-3.6
PE Ratio (ttm)	-1.09
Forward PE	-1.01
Analyst	Buy

Ask	3.94
Volume	215,465
Avg. Volume (20D)	411,698
Open	3.68
Previous Close	3.63
Day's Range	3.60 - 3.94
52-Week Range	1.78 - 7.85
Beta	3.10

About KYTX

undefined

[Read more]

Industry n/a

Sector n/a

IPO Date n/a

Employees NaN

Stock Exchange n/a

Ticker Symbol KYTX

Website n/a

Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for KYTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts

Why Price Moved

3 months ago

+13.66%

Kyverna Therapeutics shares are trading higher aft... Unlock content with Pro Subscription

News

2 weeks ago · benzinga.com

Kyverna Sets Pace In Race For Autoimmune CAR-T Approval By 2026

The biotechnology sector is experiencing a surge in innovation as companies develop advanced therapies to address complex diseases. This wave of progress is particularly evident in the development of ...

2 months ago · https://www.defenseworld.net

Squarepoint Ops LLC Acquires New Holdings in Kyverna Therapeutics, Inc. (NASDAQ:KYTX)

Squarepoint Ops LLC acquired a new stake in Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Free Report) during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm ...